MANAGEMENT


Andrew M. Flanagan – President and Chief Executive Officer

Andrew M. Flanagan is the President and Chief Executive Officer of IMRIS and a member of the company’s Board of Directors. Andy oversees the global management of IMRIS and the success of the company’s leading intraoperative solutions. He leads a seasoned management team dedicated to creating and delivering patient-centricity, healthcare innovations that are safe, effective and proven to improve patient lives. Andy’s emphasis on customer success drives the company’s growth strategy.

Andy has an extensive and diverse leadership background having worked in senior roles for Siemens, SAP and Xerox. In addition, he founded an enterprise software company and led an early stage digital health company as the CEO. While at Siemens, Andy was the Senior Vice President of health services sales and business management within the customer solutions division of Siemens Healthcare, North America. In this role, he drove sales performance, services execution and customer satisfaction of the $1B+ Siemens healthcare software business in the United States.

Andy earned a Bachelor of Science from the University of Nevada, Management School of Business, Reno, Nev., and his Master’s in health informatics at Northwestern University, Evanston, Ill.

Meir Dahan – Executive Vice President, Research & Development and Chief Technology Officer

As Executive Vice President, research and development and chief technology officer, Mr. Dahan is responsible for creating and leading the company’s global technology vision, strategy, and direction that is focused on bringing enhanced visualization to the point of therapy. He has an extensive technical and managerial background along with an outstanding record in developing high-quality innovative products and a proven ability to build high performance teams.

Prior to joining IMRIS in 2008, Meir has worked to design, develop and launch commercial product platforms with world-renowned corporations such as Baxter Healthcare, 3Com Corporation and US Robotics. He is credited with leading R&D teams that have generated over 130 patents in the area of medical devices and he has personally been awarded over a dozen patents. Meir was recognized for induction of surgical robotic technologies in the 2014 Space Technology Hall of Fame and spoke on Surgical Robots in Concert with the Wider OR Ecosystem in 2015 at the annual Medical Design & Manufacturing meeting.

He holds a Master in Business Administration and a Master of Science in electrical engineering from the Illinois Institute of Technology, Chicago, Ill., and a Bachelor of Science in electrical engineering from Ben Gurion University, Be’er Sheva, Israel.

Maurice Holloman – Executive Vice President, Operations

Mr. Holloman has served as IMRIS’ Executive Vice President, operations and has been a member of the senior leadership team since 2013. In this role, he and his team are responsible for safe, reliable operations across the globe, which include global manufacturing, supply chain management, and program management.

As a seasoned executive, Maurice has a track record of delivering strong results, leading large teams and developing innovative strategies. He has an extensive background in project engineering, site operations management, plant management, supply chain management and operations. Prior to joining IMRIS, Maurice held various operational leadership positions with Medtronic, Novartis Nutrition, ConAgra Foods and Procter & Gamble, Co.

He holds a bachelor’s degree in civil engineering from the Georgia Institute of Technology, Atlanta, Ga., and a Master in Business Administration from the University of Phoenix, Tempe, Ariz.

Robert Korn – Sr. Vice President, Global Sales and Marketing

With more than 25 years of experience in the Health Care Industry focused in medical device sales and marketing, Korn is a highly distinguished leader with a track record of successfully growing companies and market share while cultivating long-term relationships with healthcare customers and partners. He has an impressive background in developing and implementing best-in-class sales and marketing strategies for both Fortune 500 and start-up companies. Korn joins IMRIS from MRI Interventions, Inc. where he was accountable for all sales and clinical activities in the United States and successfully increased revenue and account installation base for their flagship product, a MRI guided navigation system that enables numerous clinical interventions in the cranial based neurosurgical arena.

Sarah Fyfe – Vice President of Talent & Culture

As Vice President of Talent and Culture, Sarah Fyfe is responsible for cultivating and building high performing teams to deliver against IMRIS’ vision and strategy. Through managing internal relations, building benchmark talent pools and fostering organizational effectiveness, her work focuses on driving a cohesive culture in which both employees and IMRIS thrive.

Across multiple industries, Sarah has a broad variety of human capital management experience including Organizational Design & Effectiveness, Recruiting, Employee Relations, Total Rewards and Learning & Development. Most recently, Sarah comes from Hallmark Cards, Inc. where she held various roles within a broad array of Human Resource disciplines.

She holds a Master’s Degree in Human Resources and Industrial Relations from the Carlson School of Management at the University of Minnesota, Minneapolis, MN, and a Bachelor’s Degree in Psychology from Santa Clara University, Santa Clara, CA.

Christopher Monnot – Vice President of Finance/Controller

As Vice President of Finance/Controller, Christopher is essential to the future of our company and our mission.

A leader, an organizer and a visionary, Christopher helps maximize IMRIS’ efficiency and prepare us for what’s next – while establishing the stability that allows our teams to innovate boldly. His work ranges from FP&A and business development to process-improvement and supply-chain management.

While much of his role is behind-the-scenes, Christopher has a profound impact on IMRIS’ mission: to elevate the human experience. With his guidance, our investors and our partners have confidence; our company has the ability to grow and evolve; and our employees have the opportunity to elevate the human experience for the patients, surgeons and hospitals we serve.

BOARD OF DIRECTORS


Gregory Sorensen, MD

Dr. Sorensen is the Executive Chairman of the Board of Directors for IMRIS, the leader in image guided therapy solutions. As head of the board, Greg brings a deep understanding of technology, the biological basis of disease, the importance of measurable outcomes, and the environment of clinical practice. He was appointed to the board of directors in October 2015. He is a Neuroradiologist, well known in the industry for his innovative research in medical imaging and for his expertise in clinical practice.

Before joining IMRIS, Greg served as the president and CEO of Siemens Healthcare North America. Prior to Siemens, he served as Professor of Radiology and Health Sciences & Technology at Harvard Medical School; a faculty member of the Harvard-MIT Division of Health Sciences and Technology; and co-director of the A.A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, as well as a visiting Professor of Neuroradiology at Oxford University.

Leading up to his appointment with Siemens, Greg was a practicing Neuroradiologist and active researcher with significant experience in clinical care, clinical trials, and translational research. His research and techniques are utilized by numerous centers throughout the world in phase II and III trials in cancer, stroke, and other illnesses. He holds a B.S. in biology from California Institute of Technology, Pasadena, CA, a M.S. in computer science from Brigham Young University, Provo, Utah, and a medical degree from Harvard Medical School, Boston, Mass.

Andrew M. Flanagan

Andrew M. Flanagan is the President and Chief Executive Officer of IMRIS and a member of the company’s Board of Directors. Andy oversees the global management of IMRIS and the success of the company’s leading intraoperative solutions. He leads a seasoned management team dedicated to creating and delivering patient-centricity, healthcare innovations that are safe, effective and proven to improve patient lives. Andy’s emphasis on customer success drives the company’s growth strategy.

Andy has an extensive and diverse leadership background having worked in senior roles for Siemens, SAP and Xerox. In addition, he founded an enterprise software company and led an early stage digital health company as the CEO. While at Siemens, Andy was the senior vice president of health services sales and business management within the customer solutions division of Siemens Healthcare, North America. In this role, he drove sales performance, services execution and customer satisfaction of the $1B+ Siemens healthcare software business in the United States.

Andy earned a Bachelor of Science from the University of Nevada, Management School of Business, Reno, Nev., and his Master’s in health informatics at Northwestern University, Evanston, Ill.

Steven Swanson, MD, MBAA

Dr. Swanson recently retired from Medtronic, plc as Vice President and Chief Medical Officer for the Restorative Therapies Group (RTG) and is now the President and Principal Consultant for 3Pines M.D. Strategies, LLC; a boutique healthcare consulting firm specializing in physician executive leadership coaching, health system neuroscience center development, and medical device industry corporate healthcare strategies.

Dr. Swanson joined Medtronic in January 2014 as Vice President and Chief Medical Officer for the Restorative Therapies Group (RTG). Steve had direct responsibility for the Medical Affairs and Medical Safety functions in Neuromodulation and participated in the strategic planning for the senior leadership team. He also provided oversight for RTG Medical Affairs and Safety and played a role in key strategic growth initiatives including the Medtronic Neuroscience strategy as well as business development initiatives.

Prior to joining Medtronic, Dr. Swanson served as the President of the Neurosciences and Spine Clinical Service Line for Allina Health in Minneapolis, Minnesota. In that role, he provided both clinical and business oversight for all of neuroscience and spine services at Allina Health in Minneapolis, Minnesota. Along with clinical and administrative leaders, he led the development of multi-disciplinary clinical programs in Epilepsy, Neuro-oncology, Spine, and Neurovascular Care. In addition, he provided clinical project management for the new Bentson Family Foundation Neurological Intensive Care Unit at United Hospital in St. Paul and the first Nasseff Spine Center at WestHealth (Abbott Northwestern Hospital) in Plymouth, Minnesota. In 2012, Dr. Swanson was named as the first President of the John Nasseff Neuroscience Institute at Allina Health.

Dr. Swanson’s clinical practice and leadership career included a general adult neurosurgical practice with the Michigan Brain and Spine Institute in Ann Arbor, Michigan and more recently, the Mayo Clinic Health System in Eau Claire, Wisconsin. Additionally, he served in a variety of medical staff and neurosurgical specialty society leadership roles throughout his 25 year clinical career.

Dr. Swanson is a graduate of St. Olaf College with a B.A., Magna Cum Laude in Biology and Chemistry. He earned his MD degree at Mayo Medical School in Rochester, Minnesota and completed a residency in Neurological Surgery at the University of Michigan, serving as Chief Resident in 1984-1985. Recently he completed the Healthcare MBA program at the University of St. Thomas in Minneapolis, Minnesota.

David Clark

David is a Partner and General Counsel at Deerfield Management who serves as a member of the Private Transactions team. David joined Deerfield Management in 2009 with more than 30 years’ experience as a lawyer and business executive. Prior to Deerfield Management, David spent 10 years as a transactional lawyer with the Charlotte, North Carolina, firm of Robinson, Bradshaw & Hinson, where he led the firm’s pharmaceutical practice. Previously, David was with United Dominion Industries, a diversified manufacturing company where he served as a legal, corporate development, and international operations officer. David received an A.B. from Dartmouth College and a J.D. from The University of Texas at Austin.

Steve Hochberg

Steve has helped build, launch and grow innovative companies that have changed not only the healthcare industry, but the world.

Now, as a partner on the Private Transactions team at Deerfield Management, Steve is leveraging more than 2 decades of experience – to help us elevate not only the medical experience, but the human experience.

Steve’s credentials include:

  • Senior Vice Chairman of the Mount Sinai Health System, an integrated healthcare delivery system with over $5 billion in annual revenues.
  • Co-Founder and Manager of Ascent Biomedical Ventures, a leading venture capital firm focused on early-stage investment and development of biomedical companies. 
  • Graduate of the Harvard Business School.